A single session of aerobic exercise reduces systolic blood pressure at rest and in response to stress in women with rheumatoid arthritis and hypertension

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2024
DOI
Scopus
Web of Science
PubMed
Dimensions
Título da Revista
ISSN da Revista
Título do Volume
Editora
SPRINGERNATURE
Autores
BRITO, Leandro Campos de
FECCHIO, Rafael Yokoyama
Citação
JOURNAL OF HUMAN HYPERTENSION, v.38, n.2, p.168-176, 2024
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Rheumatoid arthritis (RA) is an autoimmune inflammatory disease characterized by increased risk of cardiovascular disease and hypertension (HT). A single session of aerobic exercise may reduce blood pressure (BP) in different clinical groups; however, little is known about the acute effects of exercise on BP in RA patients. This is a randomized controlled crossover study that assessed the effects of a single session of aerobic exercise on resting BP, on BP responses to stressful stimuli, and on 24-h BP in women with RA and HT. Twenty women with RA and HT (53 +/- 10 years) undertook sessions of 30-min treadmill exercise (50% VO2max) or control (no exercise) in a crossover fashion. Before and after the sessions, BP was measured at rest, and in response to the Stroop-Color Word Test (SCWT), the Cold Pressor Test (CPT), and an isometric handgrip test. After the sessions, participants were also fitted with an ambulatory BP monitor for the assessment of 24-h BP. A single session of exercise reduced resting systolic BP (SBP) (-5 +/- 9 mmHg; p < 0.05), and reduced SBP response to the SCWT (-7 +/- 14 mmHg; p < 0.05), and to the CPT (-5 +/- 11 mmHg; p < 0.05). Exercise did not reduce resting diastolic BP (DBP), BP responses to the isometric handgrip test or 24-h BP. In conclusion, a single session of aerobic exercise reduced SBP at rest and in response to stressful stimuli in hypertensive women with RA. These results support the use of exercise as a strategy for controlling HT and, hence, reducing cardiovascular risk in women with RA.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/58798
Referências
  1. ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302
  2. Avina-Zubieta JA, 2012, ANN RHEUM DIS, V71, P1524, DOI 10.1136/annrheumdis-2011-200726
  3. Baghdadi LR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117952
  4. Brito LC, 2018, J AM SOC HYPERTENS, V12, pE59, DOI 10.1016/j.jash.2018.10.006
  5. CALLISTER R, 1992, J PHYSIOL-LONDON, V454, P373, DOI 10.1113/jphysiol.1992.sp019269
  6. Cardoso CG, 2010, CLINICS, V65, P317, DOI 10.1590/S1807-59322010000300013
  7. Carpio-Rivera E, 2016, ARQ BRAS CARDIOL, V106, P422, DOI 10.5935/abc.20160064
  8. de Brito LC, 2019, INT J SPORTS MED, V40, P487, DOI 10.1055/a-0938-4415
  9. del Rincón I, 2005, ARTHRITIS RHEUM-US, V52, P3413, DOI 10.1002/art.21397
  10. Dempsey PC, 2018, HYPERTENSION, V72, P1037, DOI 10.1161/HYPERTENSIONAHA.118.11190
  11. Di Minno MND, 2015, EUR J INTERN MED, V26, P835, DOI 10.1016/j.ejim.2015.10.016
  12. Fecchio RY, 2020, J HUM HYPERTENS, V34, P719, DOI 10.1038/s41371-020-0297-5
  13. Gibofsky Allan, 2012, Am J Manag Care, V18, pS295
  14. Green DJ, 2017, PHYSIOL REV, V97, P495, DOI 10.1152/physrev.00014.2016
  15. Halliwill JR, 2013, EXP PHYSIOL, V98, P7, DOI 10.1113/expphysiol.2011.058065
  16. Hamer M, 2006, BIOL PSYCHOL, V71, P183, DOI 10.1016/j.biopsycho.2005.04.004
  17. JOHNSON AG, 1994, ANN INTERN MED, V121, P289, DOI 10.7326/0003-4819-121-4-199408150-00011
  18. Moore N, 2020, DRUG SAFETY, V43, P301, DOI 10.1007/s40264-019-00900-8
  19. Myasoedova E, 2014, J RHEUMATOL, V41, P1638, DOI 10.3899/jrheum.131170
  20. Nobre F, 2018, ARQ BRAS CARDIOL, V110, P1
  21. Panoulas VF, 2008, RHEUMATOLOGY, V47, P1286, DOI 10.1093/rheumatology/ken159
  22. Panoulas VF, 2007, RHEUMATOLOGY, V46, P1477, DOI 10.1093/rheumatology/kem169
  23. Peçanha T, 2021, J PHYSIOL-LONDON, V599, P927, DOI 10.1113/JP280892
  24. Protogerou AD, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4324
  25. Scarpina F, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00557
  26. Barroso WKS, 2021, ARQ BRAS CARDIOL, V116, P516, DOI 10.36660/abc.20201238
  27. Skeoch S, 2015, NAT REV RHEUMATOL, V11, P390, DOI 10.1038/nrrheum.2015.40
  28. Stalnikowicz R, 2002, AM J EMERG MED, V20, P488, DOI 10.1053/ajem.2002.34788
  29. STAMLER R, 1991, HYPERTENSION, V17, pI16, DOI 10.1161/01.HYP.17.1_Suppl.I16
  30. Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651
  31. VICTOR RG, 1987, HYPERTENSION, V9, P429, DOI 10.1161/01.HYP.9.5.429
  32. Vladimirova N, 2015, ARTHRITIS, DOI 10.1155/2015/434109
  33. WHO O, 2020, WHO GUID PHYS ACT SE, P1
  34. WOOD DL, 1984, HYPERTENSION, V6, P301, DOI 10.1161/01.HYP.6.3.301

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM